Phase I-II studies of docetaxel as a single agent in the treatment of metastatic breast cancer.
about
'Who', 'when' and 'how' in re-irradiation of recurrent painful bone metastases.Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines.Ixabepilone as monotherapy or in combination for the treatment of advanced breast cancer.
P2860
Phase I-II studies of docetaxel as a single agent in the treatment of metastatic breast cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Phase I-II studies of docetaxe ...... t of metastatic breast cancer.
@ast
Phase I-II studies of docetaxe ...... t of metastatic breast cancer.
@en
type
label
Phase I-II studies of docetaxe ...... t of metastatic breast cancer.
@ast
Phase I-II studies of docetaxe ...... t of metastatic breast cancer.
@en
prefLabel
Phase I-II studies of docetaxe ...... t of metastatic breast cancer.
@ast
Phase I-II studies of docetaxe ...... t of metastatic breast cancer.
@en
P1433
P1476
Phase I-II studies of docetaxe ...... t of metastatic breast cancer.
@en
P2093
M E Trudeau
P433
P577
1999-06-01T00:00:00Z